AB6755

Rabbit Anti-Human IgG H&L (FITC)

Name: Rabbit Anti Human (IgG) secondary antibody FITC (ab6755) | Abcam
Brand: Abcam Limited
SKU: AB6755
Price: 265 USD
Availability: InStock

Be the first to review this product! Submit a review

(2 Publications)

Suitable for IHC-Fr, ELISA, IM, Flow Cyt, ICC/IF. Cited in 2 publications.

View Alternative Names

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1

Unconjugated

Rabbit Anti-Human IgG H&L
Alkaline Phosphatase

Rabbit Anti-Human IgG H&L (Alkaline Phosphatase)
615 Texas Red®

Rabbit Anti-Human IgG H&L (Texas Red ®)
Biotin

Rabbit Anti-Human IgG H&L (Biotin) preadsorbed
572 TRITC

Rabbit Anti-Human IgG H&L (TRITC)
576 DyLight® 550

Rabbit Anti-Human IgG H&L (DyLight® 550) preadsorbed
Unconjugated

Rabbit Anti-Human IgG H&L preadsorbed
673 DyLight® 650

Rabbit Anti-Human IgG H&L (DyLight® 650) preadsorbed
618 DyLight® 594

Rabbit Anti-Human IgG H&L (DyLight® 594)
HRP

Rabbit Anti-Human IgG H&L (HRP)
518 DyLight® 488

Rabbit Anti-Human IgG H&L (DyLight® 488) preadsorbed

Key facts

Host species

Rabbit

Target species

Human

Target isotype

IgG

Target specificity

Heavy & Light chains

Minimal cross-reactivity

Pre-adsorbed

Conjugation

FITC

Excitation/Emission

Ex: 495nm, Em: 519nm

Applications

Flow Cyt, IHC-Fr, ELISA, ICC/IF, IM

applications

Clonality

Polyclonal

style

left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "IHC-Fr": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"", "notes":"" }, "ELISA": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"1/10000 - 1/50000", "notes":"" }, "IM": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"1/1000 - 1/5000", "notes":"" }, "Flow Cyt": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"1/500 - 1/2500", "notes":"" }, "ICC/IF": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"1/1000 - 1/5000", "notes":"" } } }

style

left-column

style

left-column

Properties and storage information

Form

Liquid

Purification technique

Affinity purification

Purification notes

This product was prepared from monospecific antiserum by immunoaffinity chromatography using Human IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities.

Storage buffer

Preservative: 0.01% Sodium azide Constituents: 1% BSA, 0.88% Sodium chloride, 0.424% Potassium phosphate solution

Shipped at conditions

Blue Ice

Appropriate short-term storage conditions

+4°C

Appropriate long-term storage conditions

+4°C

style

left-column

style

left-column

style

left-column

Product protocols

Visit the General protocols
Visit the Troubleshooting

style

left-column

Target data

Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed : 20176268, PubMed : 22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed : 17576170, PubMed : 20176268). Mediates IgG effector functions on monocytes triggering ADCC of virus-infected cells.

See full target information IGHG1

Additional targets

IGHG3,IGHG2,IGHG4

style

left-column

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Oncology letters 24:347 PubMed36072001

2022

Lidocaine inhibits the proliferation and migration of endometrial cancer cells, and promotes apoptosis by inducing autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Dingde Long,Yayu Chen,Liangchao Qu,Yang Dong

Oncology letters 18:6787-6794 PubMed31788123

2019

Long noncoding RNA IRAIN acts as tumor suppressor via miR-125b in multiple myeloma.

Applications

Unspecified application

Species

Unspecified reactive species

Yanxia Jiang,Jian Chen,Guoan Chen

View all publications

style

left-column

style

left-column

style

right-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.

For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com

Rabbit Anti-Human IgG H&L (FITC)

Related conjugates and formulations (11)

Key facts

Host species

Target species

Target isotype

Target specificity

Minimal cross-reactivity

Pre-adsorbed

Conjugation

Excitation/Emission

Applications

Clonality

Reactivity data

Properties and storage information

Form

Purification technique

Purification notes

Storage buffer

Shipped at conditions

Appropriate short-term storage conditions

Appropriate long-term storage conditions

Product protocols

Target data

Additional targets

Publications (2)

Complementary Products

Primary Antibodies

Secondary Antibodies

Primary Antibodies

Primary Antibodies

Product promise